Skip to main navigation Skip to search Skip to main content

Correction to: Mitochondrial Dynamics in SARS‑COV2 Spike Protein Treated Human Microglia: Implications for Neuro‑COVID (Journal of Neuroimmune Pharmacology, (2021), 16, 4, (770-784), 10.1007/s11481-021-10015-6)

  • SUNY Buffalo
  • Roswell Park Cancer Institute
  • SUNY Albany

Research output: Contribution to journalComment/debate

Abstract

In the published article “Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. Clough E, Chean KT, Inigo J, Tubbesing KE, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, Schwartz SA, Khmaladze A, Mahajan SD. J Neuroimmune Pharmacol. 2021 Oct 2:1–15.https://doi.org/10.1007/s11481-021-10015-6.” Author names Chean KT and Tubbesing KE needed to be deleted from the list of authors at their request. The Editorial Office of Journal of Neuroimmune Pharmacology has approved this correction. The corresponding author apologizes for any inconvenience that it may have caused. The correct Authors list should be: Clough E, Inigo J, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, Schwartz SA, Khmaladze A, Mahajan SD. And the article should now be cited as Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. Clough E, Inigo J, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, Schwartz SA, Khmaladze A, Mahajan SD. J Neuroimmune Pharmacol. 2021 Oct 2:1–15. The original article has been corrected.

Original languageEnglish
Pages (from-to)380
Number of pages1
JournalJournal of Neuroimmune Pharmacology
Volume17
Issue number3-4
DOIs
StatePublished - Dec 2022

Fingerprint

Dive into the research topics of 'Correction to: Mitochondrial Dynamics in SARS‑COV2 Spike Protein Treated Human Microglia: Implications for Neuro‑COVID (Journal of Neuroimmune Pharmacology, (2021), 16, 4, (770-784), 10.1007/s11481-021-10015-6)'. Together they form a unique fingerprint.

Cite this